SCR-LIP-000226 · Claim · machine-readable JSON →
A GWAS of an inferred lipedema phenotype in UK Biobank women identified 18 genome-wide significant loci (SNP heritability ~5.13%), including RSPO3 (OR=1.24), GRB14-COBLL1, VEGFA, and ADAMTS9 (some replicated in an independent clinically-diagnosed lipedema cohort), with genetic correlations to body fat, leptin levels, and age at menopause.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- moderate (GRADE)
- Evidence
- 1 source(s)
- Answers
- 3 question(s)
- Dates
- 2026-05-31 → 2026-05-31
Structured evidence, machine-compiled — not a verdict.
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31
Evidence over time
Evidence (1)
- Genome-wide association study of a lipedema phenotype among women in the UK Biobank identifies multiple genetic risk factors — Klimentidis et al. (2023) ✓ verified — consistent · cross sectional · 2023 · reading confidence: high
This genome-wide association study identifies heritable genetic risk loci for a lipedema phenotype, directly supporting a hereditary influence; genetic correlations with leptin and age at menopause also touch on hormonal/endocrine links. Co
Context (PECO)
Answers these questions
- Do hormones and heredity influence the onset of lipedema? consistent
- Do hormonal factors (puberty, pregnancy, menopause, estrogen) trigger or influence lipedema onset? consistent
- Is lipedema onset influenced by heredity and family history? consistent
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-05-31 — created · auto-ingested for SQ-LIP-000012